204 related articles for article (PubMed ID: 23424037)
1. Sinonasal rhabdomyosarcoma: prognostic factors and treatment outcomes.
Thompson CF; Kim BJ; Lai C; Grogan T; Elashoff D; St John MA; Wang MB
Int Forum Allergy Rhinol; 2013 Aug; 3(8):678-83. PubMed ID: 23424037
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic outcome and prognostic factors in sinonasal rhabdomyosarcoma: a single-institution case series.
Li W; Lu H; Wang D
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2793-2802. PubMed ID: 31444550
[TBL] [Abstract][Full Text] [Related]
3. A Population-Based Analysis of Survival for Sinonasal Rhabdomyosarcoma.
Unsal AA; Chung SY; Unsal AB; Baredes S; Eloy JA
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):142-149. PubMed ID: 28397540
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic traits and prognostic factors associated with pediatric sinonasal rhabdomyosarcoma.
Siddiqui SH; Siddiqui E; Bavier RD; Patel NM; Kiliç S; Baredes S; Hsueh WD; Eloy JA
Int Forum Allergy Rhinol; 2019 Apr; 9(4):363-369. PubMed ID: 30629809
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children.
Callender TA; Weber RS; Janjan N; Benjamin R; Zaher M; Wolf P; el-Naggar A
Otolaryngol Head Neck Surg; 1995 Feb; 112(2):252-7. PubMed ID: 7838548
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in Adult Sinonasal Rhabdomyosarcoma.
Stepan K; Konuthula N; Khan M; Parasher A; Del Signore A; Govindaraj S; Genden E; Iloreta A
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):135-141. PubMed ID: 28669309
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
8. Adherence to Treatment, Response and Patterns of Failure in Pediatric Parameningeal Rhabdomyosarcoma: Experience From a Tertiary Cancer Care Center From India.
Roy S; Pathy S; Mohanti BK; Chander S; Biswas A
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e62-e68. PubMed ID: 28060113
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma.
Lo WL; Huang WH; Yeh CF
In Vivo; 2022; 36(6):2965-2972. PubMed ID: 36309350
[TBL] [Abstract][Full Text] [Related]
10. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group.
Pappo AS; Anderson JR; Crist WM; Wharam MD; Breitfeld PP; Hawkins D; Raney RB; Womer RB; Parham DM; Qualman SJ; Grier HE
J Clin Oncol; 1999 Nov; 17(11):3487-93. PubMed ID: 10550146
[TBL] [Abstract][Full Text] [Related]
11. Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis.
Khademi B; Moradi A; Hoseini S; Mohammadianpanah M
Oral Maxillofac Surg; 2009 Dec; 13(4):191-9. PubMed ID: 19795137
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of sinonasal chondrosarcoma in 47 cases].
Li WP; Lu HY; Wang H; Zhang HK; Liu Q; Sun XC; Hu L; Wang DH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):14-20. PubMed ID: 31954383
[No Abstract] [Full Text] [Related]
13. Rhabdomyosarcomas of the nose and paranasal sinuses: treatment results in 15 cases.
Wurm J; Constantinidis J; Grabenbauer GG; Iro H
Otolaryngol Head Neck Surg; 2005 Jul; 133(1):42-50. PubMed ID: 16025051
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review.
Gray ST; Herr MW; Sethi RK; Diercks G; Lee L; Curry W; Chan A; Clark J; Holbrook EH; Rocco J; Sadow PM; Lin DT
Head Neck; 2015 Mar; 37(3):366-74. PubMed ID: 24421248
[TBL] [Abstract][Full Text] [Related]
15. Treatment Outcomes and Prognostic Factors of Adult Sinonasal Sarcomas: A Single-Institution Case Series.
Ding J; Wang C; Xiang J; Shen C; Hu C; Xu T; Lu X
Med Sci Monit; 2018 Sep; 24():6113-6118. PubMed ID: 30173244
[TBL] [Abstract][Full Text] [Related]
16. Management of paediatric sinonasal rhabdomyosarcoma.
Fyrmpas G; Wurm J; Athanassiadou F; Papageorgiou T; Beck JD; Iro H; Constantinidis J
J Laryngol Otol; 2009 Sep; 123(9):990-6. PubMed ID: 19393123
[TBL] [Abstract][Full Text] [Related]
17. Sinonasal cancer: Analysis of oncological failures in 156 consecutive cases.
Mirghani H; Mortuaire G; Armas GL; Hartl D; Aupérin A; El Bedoui S; Chevalier D; Lefebvre JL
Head Neck; 2014 May; 36(5):667-74. PubMed ID: 23606521
[TBL] [Abstract][Full Text] [Related]
18. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.
Lee YC; Lee TJ; Tsang NM; Huang Y; Hsu CL; Hsin LJ; Lee YH; Chang KP
J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):12. PubMed ID: 29402308
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Characteristics, Survival Outcomes, and Prognostic Factors in Adult Patients With Sinonasal Rhabdomyosarcoma: Insights from a Retrospective Cohort Study.
Durzynska M; Dos Santos FLC; Michalek IM
Anticancer Res; 2023 Oct; 43(10):4517-4524. PubMed ID: 37772581
[TBL] [Abstract][Full Text] [Related]
20. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
Viswanathan AN; Grier HE; Litman HJ; Perez-Atayde A; Tarbell NJ; Neuberg D; Shamberger RC; Marcus KJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1208-14. PubMed ID: 15001265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
